About RXMP THERAPEUTICS, INC.
RxMP Therapeutics, INC is a company developing novel systemically-delivered hemostatic agents based on red cell-derived microparticles (RMPs) to prevent and treat excessive bleeding. The company aims to improve healthcare outcomes while reducing the need for blood transfusions.
Development of novel hemostatic agents based on red cell-derived microparticles (RMPs)Systemic delivery of hemostatic agents to arrest or prevent excessive bleedingPlatform technology that reduces the risk of undesirable clotting elsewhere in the body
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RXMP THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.